ATOM

The Accelerating Therapeutics for Opportunities in Medicine, or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform. The public-private ATOM consortium aims to transform drug discovery from a…